{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:02:51Z","timestamp":1791169371556,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.031","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T10:22:20Z","timestamp":1245925340000},"page":"5419-5426","source":"Crossref","is-referenced-by-count":49,"title":["Rational design and immunogenicity of liposome-based diepitope constructs: Application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen"],"prefix":"10.1016","volume":"27","author":[{"given":"Fatouma","family":"Said Hassane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Phalipon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"B\u00e9lot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Mulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Schuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.06.031_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2009.06.031_bib2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/S0264-410X(00)00552-1","article-title":"Conjugates and reverse vaccinology to eliminate bacterial meningitis","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.031_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/156802608783378864","article-title":"Recent developments in synthetic oligosaccharide-based bacterial vaccines","volume":"8","author":"Pozsgay","year":"2008","journal-title":"Curr Top Med Chem"},{"issue":"5683","key":"10.1016\/j.vaccine.2009.06.031_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.1095209","article-title":"A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b","volume":"305","author":"Verez-Bencomo","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib5","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.031_bib6","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1128\/IAI.73.9.5835-5841.2005","article-title":"Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein","volume":"73","author":"Baraldo","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221107779814140","article-title":"Nanocarriers for systemic and mucosal vaccine delivery","volume":"1","author":"Shahiwala","year":"2007","journal-title":"Recent Pat Drug Deliv Formul"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(91)90120-5","article-title":"Liposomes as carriers of antigens and adjuvants","volume":"140","author":"Alving","year":"1991","journal-title":"J Immunol Methods"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.031_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0167-7799(00)89017-4","article-title":"Engineering liposomes for drug delivery: progress and problems","volume":"13","author":"Gregoriadis","year":"1995","journal-title":"Trends Biotechnol"},{"issue":"8\u20139","key":"10.1016\/j.vaccine.2009.06.031_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0161-5890(97)00090-4","article-title":"Synthetic lipopeptides incorporated in liposomes: in vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen","volume":"34","author":"Fernandes","year":"1997","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.031_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0161-5890(93)90028-A","article-title":"Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A","volume":"30","author":"Friede","year":"1993","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/bc034184t","article-title":"Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes","volume":"15","author":"Roth","year":"2004","journal-title":"Bioconjug Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.031_bib13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1177\/002215540104901109","article-title":"Trafficking of surface-linked and encapsulated liposomal antigens in macrophages: an immunocytochemical study","volume":"49","author":"Fortin","year":"2001","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/intimm\/7.4.679","article-title":"Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses","volume":"7","author":"Nair","year":"1995","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/immu.1994.1024","article-title":"Endocytosis and presentation of liposome-associated antigens by B cells","volume":"4","author":"Grivel","year":"1994","journal-title":"Immunomethods"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/cb600489g","article-title":"Activating B cell signaling with defined multivalent ligands","volume":"2","author":"Puffer","year":"2007","journal-title":"ACS Chem Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.031_bib17","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2297::AID-IMMU2297>3.0.CO;2-5","article-title":"Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes","volume":"29","author":"Boeckler","year":"1999","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.031_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.bjc.6602526","article-title":"Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2\/HER2 peptide-based vaccination construct","volume":"92","author":"Roth","year":"2005","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.031_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.031_bib21","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","article-title":"Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults","volume":"69","author":"Fries","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.031_bib22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1039\/B400986J","article-title":"Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease","volume":"2","author":"Wright","year":"2004","journal-title":"Org Biomol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.031_bib23","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/chem.200400903","article-title":"Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection","volume":"11","author":"Belot","year":"2005","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.176.3.1686","article-title":"Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine","volume":"176","author":"Phalipon","year":"2006","journal-title":"J Immunol"},{"issue":"29","key":"10.1016\/j.vaccine.2009.06.031_bib25","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1073\/pnas.0801711105","article-title":"Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody","volume":"105","author":"Vulliez-Le Normand","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib26","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","article-title":"A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection","volume":"182","author":"Phalipon","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.031_bib27","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.147.8.2663","article-title":"On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs","volume":"147","author":"O'Sullivan","year":"1991","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.031_bib28","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.72.8.4884-4887.2004","article-title":"N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines","volume":"72","author":"Baraldo","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/bchm3.1989.370.1.343","article-title":"Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten","volume":"370","author":"Reitermann","year":"1989","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","article-title":"Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins","volume":"169","author":"Takeuchi","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.031_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0906-6705.2004.00233.x","article-title":"The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice","volume":"13","author":"Deiters","year":"2004","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/bc050308l","article-title":"Targeted liposomes: convenient coupling of ligands to preformed vesicles using \u201cclick chemistry\u201d","volume":"17","author":"Said Hassane","year":"2006","journal-title":"Bioconjug Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0003-9861(73)80023-2","article-title":"Fluorometric assay of proteins in the nanogram range","volume":"155","author":"Bohlen","year":"1973","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.031_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro1688","article-title":"The contribution of immunology to the rational design of novel antibacterial vaccines","volume":"5","author":"Kaufmann","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymeth.2006.05.027","article-title":"Liposomal vaccines-targeting the delivery of antigen","volume":"40","author":"Altin","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/bc990122k","article-title":"Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs","volume":"11","author":"Schelte","year":"2000","journal-title":"Bioconjug Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/BC.2001.070","article-title":"Peptide vaccines and peptide libraries","volume":"382","author":"Wiesmuller","year":"2001","journal-title":"Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4049\/jimmunol.166.1.481","article-title":"A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types","volume":"166","author":"Nardin","year":"2001","journal-title":"J Immunol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.06.031_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0928-8244(03)00069-5","article-title":"Lipopeptides: adjuvanticity in conventional and genetic immunization","volume":"37","author":"Mittenbuhler","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"37","key":"10.1016\/j.vaccine.2009.06.031_bib40","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1002\/anie.200501818","article-title":"Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen","volume":"44","author":"Buskas","year":"2005","journal-title":"Angew Chem Int Ed Engl"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.031_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nchembio.2007.25","article-title":"Robust immune responses elicited by a fully synthetic three-component vaccine","volume":"3","author":"Ingale","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.031_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cbic.200800596","article-title":"Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors","volume":"10","author":"Ingale","year":"2009","journal-title":"ChemBioChem"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.031_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0968-0896(00)82064-7","article-title":"Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates","volume":"2","author":"Toyokuni","year":"1994","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.vaccine.2009.06.031_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/ja00080a055","article-title":"Synthetic vaccines: Synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins","volume":"116","author":"Toyokuni","year":"1994","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2009.06.031_bib45","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1039\/a704127f","article-title":"Synthetic carbohydrate-based vaccines: synthesis of an l-glycero-d-manno-heptose antigen-T-epitope-lipopeptide conjugate","author":"Reichel","year":"1997","journal-title":"Chem Commun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.031_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nchembio1007-605","article-title":"A carbohydrate vaccine exceeds the sum of its parts","volume":"3","author":"Bundle","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.031_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0192-0561(94)00082-Y","article-title":"Liposomal adjuvanticity: effect of encapsulation and surface-linkage on antibody production and proliferative response","volume":"17","author":"Shahum","year":"1995","journal-title":"Int J Immunopharmacol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.031_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0264-410X(90)90008-A","article-title":"Liposomal vaccine: influence of antigen association on the kinetics of the humoral response","volume":"8","author":"Therien","year":"1990","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.031_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(02)00318-3","article-title":"Lipopeptide vaccines\u2014yesterday, today, and tomorrow","volume":"2","author":"BenMohamed","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.031_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/IAI.42.2.842-844.1983","article-title":"Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3","volume":"42","author":"Snippe","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.06.031_bib51","unstructured":"Zigterman G, Verheul A, Snippe H. Liposomes as immunadjuvants for saccharide antigens. Liposome in Drug Delivery by G Gregoriadis. In: Florence AT, Patel HM, editors. Chur, Switzerland: Harwood Academic Publisher; 1993."},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.031_bib52","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/516452","article-title":"Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection","volume":"175","author":"Robin","year":"1997","journal-title":"J Infect Dis"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.06.031_bib53","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/S0264-410X(99)00136-X","article-title":"Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines","volume":"17","author":"Robin","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.031_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.151.4.853","article-title":"Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency","volume":"151","author":"Slack","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.06.031_bib55","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:57:51Z","timestamp":1685044671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":55,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09008822"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}